Venture capital funding deals worth $100 million or more made up nearly half of all money invested so far this year, ...

Despite an unexpected slowdown in U.S. procedure growth, system placements remained healthy, and the surgical robotics company maintained its 2026 forecast for worldwide da Vinci robot procedures.

DePuy expects the technology, which doesn’t use screws, will strengthen its spine business and integrate into its Velys ...

The Exact Sciences acquisition, which closed in March, fueled more than 40% growth in Abbott’s diagnostics sales in the ...

The robot developer’s board set a July 21 date for shareholders to vote on a proposal to wind down operations amid ...

Genesis said Edwards acquired JC Medical and the rights to its J-Valve system in an August 2024 statement. According to the FTC, Edwards agreed to pay Genesis $115 million plus milestone payments, a ...

Freenome’s screening assay will compete with Guardant Health’s Shield test, which is the first blood test approved by the FDA for primary colorectal cancer screening in average-risk adults age 45 and ...

Evidence generation is a strategic imperative in medtech, driving revenue, market access, and long-term business growth. Yet, ...